Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.
Umberto MalapellePasquale PisapiaAntonino IaccarinoMassimo BarberisClaudio BellevicineHans BrunnströmDario de BiaseGiovanna De MaglioKajsa Ericson LindquistMatteo FassanGabriella FontaniniElisa GruppioniPaul HofmanSabine Merkelbach-BruseMiguel A Molina VilaAnaïs PujalsIda RapaLuisella RighiRafael RosellOliver SchildgenVerena SchildgenFernando C SchmittGiovanni TalliniSara Vander BorghtElena VigliarMarco VolanteSvenja Wagener-RyczekBirgit WeynandGiancarlo TronconePublished in: Journal of clinical pathology (2020)
The workload of molecular testing for patients with advanced-stage lung cancer during the lockdown showed little variations. Local strategies to overcome health emergency-related issues included the preference for RT-PCR tissue-based testing methodologies and, occasionally, for liquid biopsy.